Intra-Cellular Therapies, Inc. is now part of Johnson & Johnson. Learn more
US-UNB-2500053 4/2025
© 2026 Johnson & Johnson and its affiliates. All rights reserved.
Our Mission
Our mission is to deliver innovative treatments to improve the lives of individuals with neuropsychiatric, neurologic, and other disorders to reduce the burden on patients and their caregivers.
CAPLYTA is a registered trademark of Intra-Cellular Therapies, Inc.
US-CAP-2500150 3/25